860P - Impact of response to induction chemotherapy in patients with germ cell tumors (GCT) receiving salvage high-dose chemotherapy (HDCT): a study of the EBMT Solid Tumors Working Party (STWP) - Andrea Necchi, Rosalba Miceli (Milano, IT), Lars Berger (Hamburg, DE), Kathrin Schumacher (Marburg, DE), Jean Bourhis (Villejuif, FR), Daniele Laszlo (Milan,IT), Emmanuelle Nicolas-Virelizier (Lyon FR), Fikret Arpaci (Ankara, TR), Simona Secondino (Pavia, IT), Peter Dreger (Heidelberg, DE), William Kruger (Greifswal, DE), Mark Ringhoffer (Karlsruhe, DE), Ali Unal (Kayseri,TR), Arnon Nagler (Tel-Hashomer, IL), Antonio Campos (Porto, PT), Anders Wahlin (Umeå, SE), Irene Donnini (Firenze, IT), Manuela Badoglio (Paris, FR), Paolo Pedrazzoli (Pavia, IT), Francesco Lanza (Cremona, IT)

868P - Effectiveness of combination gemcitabine/paclitaxel after failure of platinum-based chemotherapy for metastatic urothelial cancer - Mariana Brandão, Carolina Camacho, Catia Faustino, Nuno Sousa, Joaquina Mauricio (Porto, PT)

898P - Primary Cytoreductive Surgery (PCS) vs Neoadjuvant Chemotherapy (NACT) for advanced Ovarian Carcinoma (aOC): decision criteria and efficacy outcomes – Hugo Nunes, Fátima Vaz, Alexandra Mayer, Ana Francisca Jorge, Teresa Margarida, Ana Opinião, António Guimarães, António Moreira (Lisbon,PT)